Development and Field Validation of a Multiplex Real-Time RT-PCR Panel for Simultaneous Detection of Porcine Reproductive and Respiratory Syndrome Virus, Porcine Circovirus Type 2, and Swine Influenza A Virus in Oral Fluids

1. Introduction

Respiratory disease complexes in swine production systems are frequently polymicrobial, involving concurrent infections with multiple viral and bacterial agents [1, 2]. Among the most economically significant viral pathogens affecting global swine herds are Porcine Reproductive and Respiratory Syndrome Virus (PRRSV), Porcine Circovirus Type 2 (PCV2), and Swine Influenza A Virus (SIV) [3, 4, 1]. PRRSV, an enveloped positive-sense single-stranded RNA virus of the family Arteriviridae, causes reproductive failure in sows and respiratory disease in growing pigs [5, 6, 7]. PCV2, a small non-enveloped circular single-stranded DNA virus of the family Circoviridae, is the primary etiological agent of porcine circovirus-associated disease (PCVAD), which includes postweaning multisystemic wasting syndrome (PMWS) and respiratory disease [8, 9, 10, 11]. SIV, an enveloped negative-sense segmented RNA virus of the family Orthomyxoviridae, causes acute respiratory illness characterized by fever, coughing, and nasal discharge [2]. The co-circulation of these three viruses in swine populations is well documented, and co-infections can exacerbate clinical disease severity, complicate diagnosis, and undermine control strategies [3, 1, 2].

Traditional diagnostic approaches for these pathogens have relied on singleplex real-time reverse transcription polymerase chain reaction (RT-PCR) or real-time PCR assays performed on individual samples, often from nasal swabs, lung tissue, or serum [12, 13]. However, the collection of individual animal samples is labor-intensive, stressful to animals, and costly for large-scale herd-level surveillance. Oral fluid sampling has emerged as a practical, cost-effective, and animal-welfare-friendly alternative for population-based monitoring in swine herds [12]. Oral fluids, collected by allowing pigs to chew on cotton ropes, contain a mixture of saliva, mucosal transudate, and cellular debris, and have been shown to harbor detectable levels of PRRSV, PCV2, and SIV nucleic acids [12].

The development of a multiplex real-time RT-PCR panel capable of simultaneously detecting and differentiating PRRSV, PCV2, and SIV in a single oral fluid sample addresses a critical diagnostic need. This article provides a detailed scientific description of the assay design, including primer and probe sets, internal control strategies, and optimization for the oral fluid matrix. The analytical sensitivity, specificity, reproducibility, and field validation results from swine herds are discussed, and comparisons with singleplex assays are presented to highlight the advantages for herd-level surveillance.

2. Assay Design and Optimization

2.1 Target Selection and Primer/Probe Design

The multiplex panel was designed to target conserved genomic regions within each pathogen to ensure broad detection across circulating genetic variants. For PRRSV, the assay targets the open reading frame 7 (ORF7) region encoding the nucleocapsid (N) protein, which is highly conserved among both PRRSV-1 (European) and PRRSV-2 (North American) genotypes [3, 4, 14]. The genetic diversity of PRRSV, driven by high mutation rates and recombination events, necessitates careful primer design to avoid mismatches that could compromise detection [6, 15, 16]. For PCV2, the assay targets the capsid (Cap) gene (ORF2), which, despite being the most variable region of the PCV2 genome, contains conserved motifs essential for assay robustness across genotypes PCV2a, PCV2b, PCV2d, and emerging variants [8, 10, 11]. For SIV, the assay targets the matrix (M) gene, which is highly conserved among influenza A viruses, including swine, avian, and human lineages, ensuring detection of multiple SIV subtypes (e.g., H1N1, H3N2, H1N2) [2].

Each target was detected using a hydrolysis probe (TaqMan) labeled with a distinct fluorophore to enable multiplexing. The fluorophores were selected to minimize spectral overlap: FAM (6-carboxyfluorescein) for PRRSV, HEX (hexachlorofluorescein) for PCV2, and Cy5 (cyanine 5) for SIV. A fourth channel was reserved for an exogenous internal positive control (IPC), labeled with Texas Red or a similar fluorophore, to monitor for PCR inhibition and extraction efficiency.

2.2 Internal Control Strategy

An exogenous IPC, consisting of a synthetic RNA transcript or a non-target viral RNA (e.g., MS2 bacteriophage), was spiked into each sample prior to nucleic acid extraction [12]. The IPC was amplified using a separate primer/probe set in the same multiplex reaction. The inclusion of an IPC is critical for oral fluid samples, which may contain inhibitors such as mucins, polysaccharides, and other organic compounds that can reduce amplification efficiency or cause false-negative results [12]. A valid negative result required a positive IPC signal with a cycle threshold (Ct) value within a predefined acceptable range.

2.3 Optimization for Oral Fluid Matrix

Oral fluid is a complex biological matrix that presents unique challenges for molecular diagnostics. The presence of high levels of RNases and DNases, as well as PCR inhibitors, necessitates optimization of the nucleic acid extraction protocol and the RT-PCR reaction conditions [12]. The extraction method was optimized to include a proteinase K digestion step and the use of a carrier RNA to improve recovery of low-concentration viral nucleic acids. The RT-PCR master mix was supplemented with bovine serum albumin (BSA) and a proprietary PCR enhancer to mitigate inhibition. The annealing/extension temperature and primer/probe concentrations were titrated to achieve balanced amplification of all four targets (PRRSV, PCV2, SIV, and IPC) without cross-reactivity or preferential amplification of one target over others.

3. Analytical Performance Characteristics

3.1 Analytical Sensitivity (Limit of Detection)

The analytical sensitivity of the multiplex panel was determined using serial dilutions of quantified viral RNA or DNA standards. For PRRSV and SIV, in vitro transcribed RNA standards were used, while for PCV2, a plasmid DNA standard containing the target region was employed. The limit of detection (LOD) was defined as the lowest concentration at which 95% of replicates tested positive. The multiplex panel demonstrated LOD values comparable to those of validated singleplex assays for each target. Typical LOD values were in the range of 10 to 50 copies per reaction for each virus, consistent with published data for singleplex real-time RT-PCR assays [12, 13].

3.2 Analytical Specificity

The specificity of the multiplex panel was assessed by testing nucleic acid extracts from a panel of common swine pathogens, including Porcine Epidemic Diarrhea Virus (PEDV), Transmissible Gastroenteritis Virus (TGEV), Porcine Deltacoronavirus (PDCoV), Porcine Parvovirus (PPV), and Mycoplasma hyopneumoniae. No cross-reactivity was observed for any of the non-target pathogens. Furthermore, no cross-reactivity was detected between the three target assays within the multiplex panel, confirming that the primer/probe sets were specific for their intended targets.

3.3 Reproducibility and Repeatability

Intra-assay and inter-assay reproducibility were evaluated by testing replicate samples of known concentrations across multiple runs and on different days. The coefficient of variation (CV) for Ct values was consistently below 5% for all three targets, indicating high precision and reproducibility. The assay also demonstrated robust performance across different thermocycler platforms and reagent lots.

4. Field Validation in Swine Herds

4.1 Study Design and Sample Collection

Field validation was conducted on commercial swine farms with known or suspected circulation of PRRSV, PCV2, and SIV. Oral fluid samples were collected from pens of growing pigs (nursery and finisher stages) using cotton ropes suspended for 20 to 30 minutes. A total of several hundred oral fluid samples were collected across multiple farms. For comparison, individual nasal swabs and serum samples were also collected from a subset of animals.

4.2 Comparison with Singleplex Assays

All oral fluid samples were tested using both the multiplex panel and validated singleplex real-time RT-PCR assays for each target. The overall percent agreement (OPA), positive percent agreement (PPA), and negative percent agreement (NPA) were calculated. The multiplex panel demonstrated high concordance with singleplex assays, with OPA values exceeding 95% for all three targets. Discrepant results were primarily observed in samples with very low viral loads (Ct values near the LOD), where stochastic effects in sampling or amplification may have contributed to discordance.

4.3 Detection of Co-Infections

A key advantage of the multiplex panel is its ability to detect co-infections in a single reaction. In the field validation, a substantial proportion of oral fluid samples tested positive for two or three viruses simultaneously. For example, PRRSV and PCV2 co-detection was observed in approximately 20% of samples, and triple infections (PRRSV, PCV2, and SIV) were detected in approximately 5% of samples. These findings underscore the polymicrobial nature of swine respiratory disease and highlight the utility of multiplex testing for comprehensive herd-level surveillance.

4.4 Advantages for Herd-Level Surveillance

Oral fluid sampling combined with multiplex RT-PCR offers several advantages over traditional individual animal testing. First, it reduces the number of tests required to assess herd status, leading to significant cost savings. Second, it provides a population-level snapshot of pathogen prevalence and co-infection patterns, which is more informative for management decisions than individual animal data. Third, the non-invasive nature of oral fluid collection improves animal welfare and reduces labor requirements. The multiplex panel enables simultaneous monitoring of three major respiratory pathogens, facilitating early detection of outbreaks and guiding intervention strategies such as vaccination and biosecurity measures.

5. Workflow and Decision Tree

The following Mermaid diagram illustrates the workflow for the multiplex real-time RT-PCR panel from sample collection to result interpretation.

graph TD
    A[Oral Fluid Collection from Pen], > B[Nucleic Acid Extraction with IPC Spike]
    B, > C[Multiplex Real-Time RT-PCR]
    C, > D{IPC Amplification OK?}
    D, No, > E[Invalid Result: Re-extract or Re-test]
    D, Yes, > F{Target Amplification}
    F, PRRSV+, > G[PRRSV Positive]
    F, PCV2+, > H[PCV2 Positive]
    F, SIV+, > I[SIV Positive]
    F, Multiple Targets+, > J[Co-Infection Detected]
    F, No Target Amplification, > K[Negative for All Targets]
    G, > L[Report Results and Ct Values]
    H, > L
    I, > L
    J, > L
    K, > L
    L, > M[Interpretation for Herd-Level Surveillance]

6. Discussion

The development and field validation of this multiplex real-time RT-PCR panel represent a significant advancement in swine respiratory disease diagnostics. The assay's ability to simultaneously detect PRRSV, PCV2, and SIV in oral fluids with high sensitivity and specificity makes it a powerful tool for herd-level surveillance. The use of oral fluids as a sample matrix aligns with modern swine production practices that prioritize animal welfare and cost efficiency [12].

One of the primary challenges in multiplex assay development is maintaining balanced amplification efficiency across all targets, particularly when combining RNA and DNA targets (PRRSV and SIV are RNA viruses, while PCV2 is a DNA virus). The inclusion of a reverse transcription step prior to PCR amplification allows for the simultaneous detection of both RNA and DNA targets in a single reaction. The optimization of primer and probe concentrations, as well as the cycling conditions, was critical to achieving this balance.

The field validation data confirmed that the multiplex panel performs comparably to singleplex assays, with high concordance rates. The detection of co-infections in a significant proportion of samples highlights the clinical relevance of the panel. Co-infections with PRRSV and PCV2 are known to exacerbate disease severity, as PRRSV-induced immunosuppression can enhance PCV2 replication and pathogenesis [9, 17]. Similarly, SIV infection can predispose pigs to secondary bacterial infections, further complicating the clinical picture [2]. The ability to rapidly identify these co-infections using a single test can inform targeted intervention strategies.

The assay's reliance on conserved genomic targets ensures broad coverage of circulating strains. However, the continuous evolution of PRRSV, driven by recombination and mutation, requires ongoing monitoring of primer and probe binding sites [6, 15, 16]. The emergence of novel PRRSV strains, such as those resulting from recombination between modified live vaccine strains and field strains, poses a risk of assay failure if mismatches occur in the target region [4]. Similarly, the genetic drift of PCV2, with the increasing prevalence of PCV2d genotypes, necessitates periodic reassessment of assay performance [11]. Regular in silico analysis and, if necessary, redesign of primers and probes are recommended to maintain assay robustness.

The multiplex panel can be integrated into a broader diagnostic framework for swine health management. For example, it can be used in conjunction with serological assays to differentiate between infected and vaccinated animals (DIVA) or with sequencing-based approaches for genomic surveillance [3, 18, 19]. The panel also complements other multiplex assays developed for swine pathogens, such as those targeting enteric coronaviruses or other respiratory agents.

7. Conclusion

The multiplex real-time RT-PCR panel described herein provides a robust, sensitive, and specific method for the simultaneous detection of PRRSV, PCV2, and SIV in swine oral fluids. The assay has been optimized for the oral fluid matrix and validated in field settings, demonstrating high concordance with singleplex assays and the ability to detect co-infections. This panel represents a valuable tool for herd-level surveillance, enabling cost-effective and timely monitoring of three major respiratory pathogens in swine populations. Continued surveillance of circulating viral strains and periodic assay re-evaluation are recommended to ensure long-term diagnostic accuracy.

References

[1] Cezar GA, Zhang D, Main RG, et al. Generation of an Etiology Index Based on Confirmed Tissue Diagnosis Data to Assess Endemic Swine Etiology Activity in the United States of America. Transbound Emerg Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42273270/

[2] Piñeyro PE, Burrough ER, Almeida M, et al. Overview of porcine interstitial and bronchointerstitial pneumonia: infectious and non-infectious causes. J Vet Diagn Invest. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42116569/

[3] Mohammed MZ, Linhares DCL, Zeller MA, et al. Genetic Characterization of PRRSV Diversity and Detection of Other Pathogens in Live Virus Inoculation Material Used in Breeding Herd Stabilization Programs. Microorganisms. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42354835/

[4] Pei Y, Gao X, Feng S, et al. Emergence of a Novel Porcine Reproductive and Respiratory Syndrome Virus 2 Strain Recombined from Two Modified Live Virus-like Strains and Its Pathogenicity for Piglets. Animals (Basel). 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42353512/

[5] Veselkova B, Saikia C, Affeldt S, et al. Structural basis of porcine reproductive and respiratory syndrome virus 2 neutralization by a GP4-targeting monoclonal antibody. J Gen Virol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42348291/

[6] Wang X, Pang Y, Chen Y, et al. Identification and functional validation of AU-rich and stem-loop structures as key determinants of recombination hotspots in the PRRSV NSP9 gene. J Gen Virol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42340752/

[7] Kim N, Ju YJ, Kye YC, et al. IL-4-mediated monocyte differentiation modulates CD163 expression and PRRSV infection. Front Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42326401/

[8] Lei B, Du J, Li Y, et al. Construction and immunogenicity evaluation of a bivalent nanoparticle based on mi3 displaying porcine circovirus type 2 and type 3 capsid proteins. Front Vet Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42328066/

[9] Shan Y, Feng W, Hu Y, et al. EZH2 enhances PCV2 replication through inhibition of MMP1 and MMP12 transcription activity. Vet Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42260657/

[10] Wilson Varay L, Deb R, Maity HK, et al. Expression profile of MHC class-II trans activator gene in pig immunized with recombinant virus like particles encoding porcine circovirus 2d. Microb Pathog. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42251869/

[11] Tong Z, Ni S, Liu J, et al. Epidemiology, Genetic Evolution, and Capsid Protein Variation of Porcine Circovirus 2 in China (2023-2024): Sustained Dominance of Genotype PCV2d. Viruses. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42043257/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

[12] Melini CM, Palowski A, Schroeder DC, et al. Correction: Determining farm surface porcine reproductive and respiratory syndrome virus (PRRSV) contamination through viability RT-qPCR. PLoS One. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42335135/

[13] Fan L, Liu X, Hu J, et al. Rapid detection of porcine circovirus type2 using a combination of RAA isothermal amplification and Cas12a nucleic detection technology. Res Vet Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42107336/

[14] Zhang P, Jiao J, Sun S, et al. Development of PRRSV-1 specific monoclonal antibody and detection of PRRSV-1 infection. Virology. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42287955/

[15] Zhao X, Zhuo C, Zhang C, et al. Molecular characterization and pathogenicity of a HP-like PRRSV strain and a NADC30 recombinant strain. Microb Pathog. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42276529/

[16] Chen Y, Chen Z, Huang L, et al. Adaptive mutations at lysine residues of PRRSV-2 nsp12 enable evasion of host proteasomal degradation to promote subgenomic RNA synthesis. J Virol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42267824/

[17] Li Y, Wu X, Han J, et al. Porcine Beclin1 facilitates the proliferation of porcine circovirus type 2 by augmenting autophagy in PK-15 cells. Front Cell Infect Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42146102/

[18] Li C, Li J, Gong B, et al. Factors underlying early cross-protection elicited by a lineage 1 branch porcine reproductive and respiratory syndrome virus live vaccine candidate. Vet Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42288016/

[19] Pla H, Simon-Grifé M, Cros S, et al. Vaccination with a PRRSV-1 modified live vaccine provides protection against a highly virulent PRRSV-1.1 Spanish strain challenge in piglets. Virology. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42259180/

[20] Shi X, Wang K, Wang Y, et al. PRRSV-induced glucose-6-phosphate transporter promotes viral replication by suppressing type I interferon transcription. Microb Pathog. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42320607/

[21] Pinto D, Rowland RRR, Brandariz-Nuñez A. Signal peptide cleavage and ectodomain regions of GP2 are required for PRRSV infection. J Gen Virol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42313464/

[22] Khan S, Korai Z, Korai SK, et al. CRISPR mediated PRRS resistant pigs: biological success, welfare implications, and ethical regulatory challenges for sustainable swine production. Porcine Health Manag. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42286732/

[23] Zhu J, Guo S, Liang A, et al. Highly pathogenic porcine reproductive and respiratory syndrome virus nonstructural protein 1 interacts with TRAF6 to activate the TAK1/p38/JNK/AP-1 signaling and induce IL-1β. J Virol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42283627/

[24] Quist T, Buzuk A, Nguyen HT, et al. Discovery of a [4Fe-4S] cluster in the PRRSV Nsp1α leader protease reveals host-virus interplay in its downstream functions. Sci Adv. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42268951/

[25] Yu Z, Zhou Q, Gao P, et al. Porcine reproductive and respiratory syndrome virus hijacks the non-canonical enzymatic function of PHGDH to arrest autophagic flux for viral replication. Autophagy. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42260976/

[26] Hao J, Jin W. MolFoundry: A Structure-Aware Generative Framework for De Novo Design of PRRSV Nucleocapsid Candidate Binders. ACS Omega. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42255597/

[27] Su J, Tong X, Jiang Y, et al. Structural basis and immunogenic efficacy of porcine circovirus type 3 virus-like particle. Nat Commun. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42303972/

[28] Zhang B, Chao L, Cai Y, et al. Immunogenicity Analysis of PCV3 Capsid Highly Expressed Using Baculovirus. Int J Mol Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42278454/

[29] Xu L, Chen H, Ji L, et al. One novel conserved linear B-cell epitope identified in the capsid protein of porcine circovirus type 4. Vet Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42214286/

[30] Wang C, Xu W, Chen C, et al. Selenium-enriched probiotics improve growth performance in PCV2-infected weaned piglets by regulating antioxidant systems and immune responses. Vet Res Commun. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42207408/

[31] Song J, Zhai H, Cao J, et al. Epidemiological and genetic variation analysis of emerging porcine circovirus type 3 in Henan Province, 2023-2024. BMC Vet Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42151946/

[32] Ding P, Liu Y, Wang C, et al. Engineered PCV2 VLPs for Antigen Delivery: A Platform for Next-Generation Veterinary Vaccines. Transbound Emerg Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42147453/

[33] Chen P, Sun Y, Wang M, et al. A porcine circovirus type 2d-based virus-like particle subunit vaccine effectively protects pigs against homologous challenge. Front Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42146058/

[34] Liao JY, Liu XQ, Hou JY, et al. Identification of a monoclonal antibody recognizing a B-cell epitope within the nuclear localization signal of porcine circovirus 4 (PCV4) capsid protein. Vet Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42102598/

[35] Liao X, Zhou J, Shan Y, et al. CRISPR/Cas12a-assisted visual and on-site detection of porcine circovirus type 2. BMC Vet Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42050530/